Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis

Neurobiology of Disease

Volumn 40, Issue 1, 2010, Pages 331-339

  Harris, Violaine K ^a   Diamanduros, Andrew ^b   Good, Pamela ^a   Zakin, Elina ^a   Chalivendra, Varun ^a   Sadiq, Saud A ^a  

^a Multiple Sclerosis Research Center of New York Inc   (United States)

^b GEORGIA SOUTHERN UNIVERSITY   (United States)

Author keywords

Amyloid; Biomarkers; Bri2; Cerebellum; Cognition; CSF; Fetuin A; Itm2b; Multiple sclerosis; Proteomics; Ribonuclease 1

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; FETUIN A; KALLIKREIN 6; PLASMINOGEN; PROTEIN BRI2 23; RIBONUCLEASE; RIBONUCLEASE 1; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CEREBELLUM DISEASE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEOMICS; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CEREBELLAR DISEASES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 77955846174     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.06.007     Document Type: Article

References (31)

1. Akiyama H., et al. Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol. (Berlin) 2004, 107:53-58.
2. Bagnato F., et al. Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis. Neurol. Sci. 2003, 24(Suppl 5):S301-S304.
3. Demetriou M., et al. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J. Biol. Chem. 1996, 271:12755-12761.
4. Dziegielewska K.M., et al. Modification of macrophage response to lipopolysaccharide by fetuin. Immunol. Lett. 1998, 60:31-35.
5. Fotinopoulou A., et al. BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. J. Biol. Chem. 2005, 280:30768-30772.
6. Ghaffar O., Feinstein A. The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr. Opin. Psychiatry 2007, 20:278-285.
7. Harris V.K., Sadiq S.A. Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making. Mol. Diagn. Ther. 2009, 13:225-244.
8. Herndon R.M., Greenstein J.I. Multiple sclerosis and demyelinating diseases. Handbook of Neurologic Rating Scales 2006, 169-193. Demos Medical Publishing, LLC, New York. R.M. Herndon (Ed.).
9. Hoftberger R., et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 2004, 14:43-50.
10. Irani D.N., et al. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 2006, 59:237-247.
11. Jersmann H.P., et al. Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin. Sci. (London). 2003, 105:273-278.
12. Kim J., et al. BRI2 (ITM2b) inhibits Abeta deposition in vivo. J. Neurosci. 2008, 28:6030-6036.
13. Krumbholz M., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 2005, 201:195-200.
14. LeVine S.M., et al. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res. 1999, 821:511-515.
15. Matsuda S., et al. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. J. Biol. Chem. 2005, 280:28912-28916.
16. Matsuda S., et al. BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate. J. Neurosci. 2008, 28:8668-8676.
17. Matsuda S., et al. Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. Neurobiol. Aging 2009.
18. McDonald W.I., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann. Neurol. 2001, 50:121-127.
19. Ombrellino M., et al. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 2001, 15:181-185.
20. Petricoin E.F., Liotta L.A. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 2004, 15:24-30.
21. Sadiq S. Multiple sclerosis. Merritt's Neurology 2005, 941-963. Lippincott Williams and Wilkins, Philadelphia. L. Rowland (Ed.).
22. Scarisbrick I.A., et al. Activity of a newly identified serine protease in CNS demyelination. Brain 2002, 125:1283-1296.
23. Scarisbrick I.A., et al. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol. Chem. 2008, 389:739-745.
24. Shiryaev S.A., et al. Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. J. Biol. Chem. 2009, 284:30615-30626.
25. Shiryaev S.A., et al. Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis. PLoS ONE 2009, 4:e4952.
26. Spreen O., Strauss E. A Compendium of Neurophychological Tests 1998, Oxford University Press, New York.
27. Teesalu T., et al. Tissue plasminogen activator as a key effector in neurobiology and neuropathology. Biochem. Soc. Trans. 2002, 30:183-189.
28. Tsachaki M., et al. BRI2 as a central protein involved in neurodegeneration. Biotechnol. J. 2008, 3:1548-1554.
29. Vidal R., et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999, 399:776-781.
30. Vidal R., et al. A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc. Natl Acad. Sci. USA 2000, 97:4920-4925.
31. Zougman A., et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J. Proteome Res. 2008, 7:386-399.